Agnès Aubouy1, Florence Migot-Nabias, Philippe Deloron. 1. Centre International de Recherches Médicales de Franceville, Unité de Parasitologie Médicale, BP 769 Franceville, Gabon. agnes_aubouy@yahoo.fr
Abstract
BACKGROUND: Plasmodium falciparum antigenic diversity and polymorphism confuses the issue of antimalarial vaccine development. Merozoite surface protein (MSP)-1 and -2 are two highly polymorphic vaccine candidates. Characterisation of their precise polymorphism in endemic regions may facilitate the design of an effective vaccine. METHODS: Isolates obtained in 52 Gabonese children presenting with uncomplicated malaria were genotyped by nested-PCR of msp-1 block 2, and msp-2 block 3, to analyze both parasite population polymorphism and clone fluctuations. RESULTS: Twenty-five and 19 different alleles were respectively obtained for msp-1 and msp-2 loci, the RO33 family of msp-1 being poorly polymorphic. Four cases of non-random distribution of alleles were reported of the FC27, and/or 3D7 families of msp-2. All but two isolates were composed of more than one genotype, and the multiplicity of infection (MOI) was 4.0. Neither parasite density nor age was related to MOI. Clone fluctuations were studied for ten subjects who were sampled again at reappearance of parasites in blood. Disappearance and reappearance of alleles were observed following treatment, suggesting difficulties in assessing polymorphism and in distinguishing reinfection from recrudescence. CONCLUSION: P. falciparum polymorphism is extensive in Southeast Gabon, and most of infections are composed of multiple clones. The fluctuation of clones contributes to parasite diversity.
BACKGROUND:Plasmodium falciparum antigenic diversity and polymorphism confuses the issue of antimalarial vaccine development. Merozoite surface protein (MSP)-1 and -2 are two highly polymorphic vaccine candidates. Characterisation of their precise polymorphism in endemic regions may facilitate the design of an effective vaccine. METHODS: Isolates obtained in 52 Gabonese children presenting with uncomplicated malaria were genotyped by nested-PCR of msp-1 block 2, and msp-2 block 3, to analyze both parasite population polymorphism and clone fluctuations. RESULTS: Twenty-five and 19 different alleles were respectively obtained for msp-1 and msp-2 loci, the RO33 family of msp-1 being poorly polymorphic. Four cases of non-random distribution of alleles were reported of the FC27, and/or 3D7 families of msp-2. All but two isolates were composed of more than one genotype, and the multiplicity of infection (MOI) was 4.0. Neither parasite density nor age was related to MOI. Clone fluctuations were studied for ten subjects who were sampled again at reappearance of parasites in blood. Disappearance and reappearance of alleles were observed following treatment, suggesting difficulties in assessing polymorphism and in distinguishing reinfection from recrudescence. CONCLUSION:P. falciparum polymorphism is extensive in Southeast Gabon, and most of infections are composed of multiple clones. The fluctuation of clones contributes to parasite diversity.
Authors: E H Hoffmann; L A da Silveira; R Tonhosolo; F J Pereira; W L Ribeiro; A P Tonon; F Kawamoto; M U Ferreira Journal: Ann Trop Med Parasitol Date: 2001-03
Authors: A Färnert; A P Arez; H A Babiker; H P Beck; A Benito; A Björkman; M C Bruce; D J Conway; K P Day; L Henning; O Mercereau-Puijalon; L C Ranford-Cartwright; J M Rubio; G Snounou; D Walliker; J Zwetyenga; V E do Rosario Journal: Trans R Soc Trop Med Hyg Date: 2001 Mar-Apr Impact factor: 2.184
Authors: N Elissa; S Karch; P Bureau; B Ollomo; M Lawoko; P Yangari; B Ebang; A J Georges Journal: J Am Mosq Control Assoc Date: 1999-03 Impact factor: 0.917
Authors: G Snounou; X Zhu; N Siripoon; W Jarra; S Thaithong; K N Brown; S Viriyakosol Journal: Trans R Soc Trop Med Hyg Date: 1999 Jul-Aug Impact factor: 2.184
Authors: Agnès Aubouy; Mohamed Bakary; Annick Keundjian; Bernard Mbomat; Jean Ruffin Makita; Florence Migot-Nabias; Michel Cot; Jacques Le Bras; Philippe Deloron Journal: Antimicrob Agents Chemother Date: 2003-01 Impact factor: 5.191
Authors: Neil Michel Longo-Pendy; Larson Boundenga; Pyazzi Obame Ondo Kutomy; Clark Mbou-Boutambe; Boris Makanga; Nancy Moukodoum; Judicaël Obame-Nkoghe; Patrice Nzassi Makouloutou; Franck Mounioko; Rodolphe Akone-Ella; Lynda Chancelya Nkoghe-Nkoghe; Marc Flaubert Ngangue Salamba; Jean Bernard Lekana-Douki; Pierre Kengne Journal: Pathogens Date: 2022-06-09
Authors: Fousseyni S Touré; Odile Ouwe-Missi-Oukem-Boyer; Jérôme Mezui-Me-Ndong; Guy Roger Ndong-Atome; Ulrick Bisvigou; Dominique Mazier; Sylvie Bisser Journal: Clin Med Res Date: 2007-06
Authors: Donald S Chen; Alyssa E Barry; Aleksandra Leliwa-Sytek; Terry-Ann Smith; Ingrid Peterson; Stuart M Brown; Florence Migot-Nabias; Philippe Deloron; Moses M Kortok; Kevin Marsh; Johanna P Daily; Daouda Ndiaye; Ousmane Sarr; Souleymane Mboup; Karen P Day Journal: PLoS One Date: 2011-02-09 Impact factor: 3.240
Authors: Hema Joshi; Neena Valecha; Anju Verma; Asha Kaul; Prashant K Mallick; Sneh Shalini; Surendra K Prajapati; Surya K Sharma; Vas Dev; Sukla Biswas; Nutan Nanda; M S Malhotra; Sarala K Subbarao; Aditya P Dash Journal: Malar J Date: 2007-05-21 Impact factor: 2.979